![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 16, 12017-12022, April 21, 2000
From the Departments of Indolicidin is a 13-residue cationic,
antimicrobial peptide-amide isolated from the cytoplasmic granules of
bovine neutrophils. The unique composition of indolicidin distinguishes
it from
Formation and Characterization of a Single Trp-Trp Cross-link
in Indolicidin That Confers Protease Stability without Altering
Antimicrobial Activity*
,
§,
, and
§**
Pathology,
§ Microbiology & Molecular Genetics, ¶ Physiology & Biophysics, and
Molecular Biology & Biochemistry, University
of California, Irvine, California 92697
-helical and
-structured cationic peptides, because five
of indolicidin's 13 residues are tryptophans:
H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2. Solid phase synthesis of indolicidin gave rise to a minor byproduct that possessed unusual fluorescence and UV absorbance properties compared with authentic indolicidin. The byproduct was purified by
combined ion exchange and reversed phase high pressure liquid chromatography steps and was shown be identical to authentic
indolicidin in its microbicidal activity against Staphylococcus
aureus, Escherichia coli, Candida
albicans, and Cryptococcus neoformans. Mass analysis of the byproduct revealed a 2-atomic mass unit reduction compared with
indolicidin, suggesting the deprotonation of two indole side chains to
form an intrachain
1,
1'-ditryptophan
derivative. We confirmed the nature of the cross-linked byproduct,
termed X-indolicidin, by absorbance and fluorescence spectroscopy,
peptide mapping, and sequence analysis. Edman degradation revealed that
Trp-6 and Trp-9 were covalently cross-linked. Compared with
indolicidin, X-indolicidin was partially resistant to digestion with
trypsin and chymotrypsin, suggesting that the ditryptophan stabilizes a
subset of molecular conformations that are protease resistant but that
are absent in the native structure.
*
This work was supported by National Institutes of Health
Grant AI22931 and funds from Large Scale Biology, Inc.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J. C. Y. Hsu and C. M. Yip Molecular Dynamics Simulations of Indolicidin Association with Model Lipid Bilayers Biophys. J., June 15, 2007; 92(12): L100 - L102. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Yeaman and N. Y. Yount Mechanisms of Antimicrobial Peptide Action and Resistance Pharmacol. Rev., March 1, 2003; 55(1): 27 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tran, P. A. Tran, Y.-Q. Tang, J. Yuan, T. Cole, and M. E. Selsted Homodimeric theta -Defensins from Rhesus macaque Leukocytes. ISOLATION, SYNTHESIS, ANTIMICROBIAL ACTIVITIES, AND BACTERIAL BINDING PROPERTIES OF THE CYCLIC PEPTIDES J. Biol. Chem., January 25, 2002; 277(5): 3079 - 3084. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |